Fanning J, Fenton B, Purohit M. Robotic radical hysterectomy. Am J Obstet Gynecol. 2008;198:649–50.
Fanning J, Trinh H. Feasibility of laparoscopic ovarian debulking at recurrence in patients with prior laparotomy debulking. Am J Obstet Gynecol. 2004;190:1394–7.
Ghezzi F, Malzoni M, Vizza E, et al. Laparoscopic staging of early ovarian cancer: results of a multi-institutional cohort study. Ann Surg Oncol. 2012;19:1589–94.
Vergote I, Trope CG, Amant F. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943–53.
Article CAS PubMed Google Scholar
Elattar A, Bryant A, Winter-Roach BA, et al. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD007565.pub2.
Article PubMed PubMed Central Google Scholar
Kang S, Nam BH. Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies. Ann Surg Oncol. 2009;16:2315–20.
Kehoe S, Hook J, Nankivell M, Jayson GC, Kitchener H, Lopes T, et al. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomized, controlled, non-inferiority trial. Lancet. 2015;386:249–57.
Fagotti A, GueliAlletti S, Corrado G, Cola E, Vizza E, Vieira M, Andrade CE, Tsunoda A, Favero G, Zapardiel I, Pasciuto T, Scambia G. The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy. Int J Gynecol Cancer. 2019;29(1):5–9.
Article CAS PubMed Google Scholar
Gupta V, Rao T, Raju K, et al. Outcomes of laparoscopic optimal interval cytoreduction surgery (LOICS) in patients with advanced ovarian cancers having low burden disease. Indian J Surg Oncol. 2023;14:270–6. https://doi.org/10.1007/s13193-022-01682-9.
Chi DS, AbuRustum NR, Sonoda Y, et al. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol. 2005;192:1614–9.
Ghezzi F, Cromi A, Uccella S, et al. Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer. Gynecol Oncol. 2007;105:409–13.
Nezhat FR, Ezzati M, Chuang L, Shamshirsaz AA, Rahaman J, Gretz H. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. Am J Obstet Gynecol. 2009;200:83.
Krivak TC, Elkas JC, Rose GS, et al. The utility of hand-assisted laparoscopy in ovarian cancer. GynecolOncol. 2005;96:72–6.
Nezhat FR, Denoble SM, Cho JE, et al. Safety and efficacy of video laparoscopic surgical debulking of recurrent ovarian, fallopian tube, and primary peritoneal cancers. JSLS. 2012;16:511–8.
Article PubMed PubMed Central Google Scholar
Chi DS, Franklin CC, Levine DA, et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. GynecolOncol. 2004;94:650–4.
GueliAlletti S, Bottoni C, Fanfani F, Gallotta V, Chiantera V, Costantini B, et al. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study. Am J Obstet Gynecol. 2016;214(503):e1-6.
Corrado G, Mancini E, Cutillo G, Baiocco E, Vici P, Sergi D, et al. Laparoscopic debulking surgery in the management of advanced ovarian cancer after neoadjuvant chemotherapy. Int J Gynecol Cancer. 2015;25:1253–7.
Favero G, Macerox N, Pfiffer T, Köhler C, da Costa MV, Estevez DizMdel P, et al. Oncologic concerns regarding laparoscopic cytoreductive surgery in patients with advanced ovarian cancer submitted to neoadjuvant chemotherapy. Oncology. 2015;89:159–66.
Article CAS PubMed Google Scholar
Tozzi R, Gubbala K, Majd HS, Campanile RG. Interval laparoscopic en-bloc resection of the pelvis (L-EnBRP) in patients with stage IIIC-IV ovarian cancer: description of the technique and surgical outcomes. Gynecol Oncol. 2016;142(3):477–83.
Melamed A, Nitecki R, Boruta DM, et al. Laparoscopy compared with laparotomy for debulking ovarian cancer after neoadjuvant chemotherapy. Obstet Gynecol. 2017;129:861–9.
GueliAlletti S, Petrillo M, Vizzielli G, Bottoni C, Nardelli F, Costantini B, Quagliozzi L, et al. Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: a single-institution retrospective case-control study. GynecolOncol. 2016;143(3):516–20.
Fanning J, Hojat R, Johnson J, Fenton B. Laparoscopic cytoreduction for primary advanced ovarian cancer. JSLS. 2010;14(1):80–2.
Article PubMed PubMed Central Google Scholar
Mahner S, Eulenburg C, Staehle A, Wegscheider K, Reuss A, Pujade-Lauraine E, et al. Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials. Eur J Cancer. 2013;49(1):142–9.
Article CAS PubMed Google Scholar
Cardenas-Goicoechea J, Wang Y, McGorray S, Saleem MD, Carbajal Mamani SL, Pomputius AF, et al. Minimally invasive interval cytoreductive surgery in ovarian cancer: systematic review and meta-analysis. J Robot Surg. 2019;13(1):23–33.
Koo YJ, Kim JE, Kim YH, et al. Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomes. J GynecolOncol. 2014;25(2):111–7.
Sinukumar S, Rajan F, Mehta S, Damodaran D, Zaveri S, Kammar P, Bhatt A. A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer—a study by INDEPSO. Eur J Surg Oncol. 2019;47(1):75–81.
Somashekhar SP, Ashwin KR, Yethadka R, Zaveri SS, Ahuja VK, Rauthan A, Rohit KC. Impact of extent of parietal peritonectomy on oncological outcome after cytoreductive surgery and HIPEC. Pleura Peritoneum. 2019;4(4):20190015. https://doi.org/10.1515/pp-2019-0015.
Article CAS PubMed PubMed Central Google Scholar
Arjona-Sanchez A, Esquivel J, Glehen O, Passot G, et al. A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: the American society of peritoneal surface malignancies (ASPSM) multi-institution analysis. Surg Endosc. 2019;33(3):854–60.
Article CAS PubMed Google Scholar
Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (HIPEC) by minimally invasive approach, an initial experience. World J Surg. 2018;42(10):3120–4.
Article CAS PubMed Google Scholar
Mercier F, Jeremie G, Alyami M, Delphine V, Vahan K, Pascal R, Sylvie I, Guillaume P, Olivier G. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxomaperitonei and multicystic mesothelioma. Surg Endosc. 2019;34:4916–23. https://doi.org/10.1007/s00464-019-07280-1.
Lim CK, Kim DY, Cho A, Choi JY, Park JY, Kim YM. Role of minimally invasive surgery in early ovarian cancer. Gland Surg. 2021;10(3):1252–9. https://doi.org/10.21037/gs-2019-ursoc-07.
Article PubMed PubMed Central Google Scholar
Falcetta FS, Lawrie TA, Medeiros LRF, da Rosa MI, Edelweiss MI, Stein AT, Zelmanowicz A, Moraes AB, Zanini RR, Rosa DD, Platt J. Laparoscopy versus laparotomy for FIGO stage I ovarian cancer. Cochrane Database Syst Rev. 2016. https://doi.org/10.1002/14651858.CD005344.pub4.
Article PubMed PubMed Central Google Scholar
Ran X, He X, Li Z. Comparison of laparoscopic and open surgery for women with early-stage epithelial ovarian cancer. Front Oncol. 2022;12:879889. https://doi.org/10.3389/fonc.2022.879889.
Article PubMed PubMed Central Google Scholar
Aoki D. Laparoscopic surgery for early ovarian cancer. J Gynecol Oncol. 2014;25(3):168–9.
Comments (0)